Physicians

Five things for pharma marketers to know: Tuesday, June 20, 2017

Five things for pharma marketers to know: Tuesday, June 20, 2017

By

Novartis reports positive Phase-III results for Eylea competitor; AZ faces "critical transition point" in MYSTIC trial; physician shortage expected to rise

Five things for pharma marketers to know: Thursday, June 15, 2017

Five things for pharma marketers to know: Thursday, June 15, 2017

By

Google invests in European biotechs; hospitals that restrict sales-rep visits more likely to prescribe cheaper generics; AI could help doctors with new research

Voice assistants may ease EHR burden for docs, but challenges exist

Voice assistants may ease EHR burden for docs, but challenges exist

By

With physicians spending nearly four hours a day on their electronic health records, experts say voice assistants could help reduce their workload one day.

Five things for pharma marketers to know: Friday, June 2, 2017

Five things for pharma marketers to know: Friday, June 2, 2017

By

Oncologists more likely to prescribe drugs when receiving travel, meal payments; Tesaro reportedly considering a sale; AbbVie has best pharma reputation

Outcome Health raises $500 million in financing round

Outcome Health raises $500 million in financing round

By

The deal highlights ongoing interest in the influential point-of-care market.

Five things for pharma marketers to know: Thursday, May 25, 2017

Five things for pharma marketers to know: Thursday, May 25, 2017

By

Fitness trackers do not reliably track calories, docs find; health-tech startups face market uncertainty; FDA adcom votes in favor of Puma breast-cancer drug

Expert Q&A: Getting patient centricity right

Expert Q&A: Getting patient centricity right

Five sector pros discuss adapting to patient-centricity and how pinpointing patient needs leads to success.

Study: One-third of docs trust pharma content on HCP sites

Study: One-third of docs trust pharma content on HCP sites

By

In general, physicians believe that information provided by pharma companies is difficult to find and lacking in science.

Five things for pharma marketers to know: Thursday, May 18, 2017

Five things for pharma marketers to know: Thursday, May 18, 2017

By

Docs spend little time telling patients about cancer costs; Shire to file hereditary angioedema drug with the FDA by 2018; Philips CEO on access obstacles

Five things for pharma marketers to know: Thursday, May 11, 2017

Five things for pharma marketers to know: Thursday, May 11, 2017

By

FDA approves Merck/Lilly combo for lung cancer; new PhRMA requirements result in expulsion of 22 members; Pfizer to pay Sangamo $7 million for gene therapy programs

5 of healthcare's hardest nuts to crack

5 of healthcare's hardest nuts to crack

How are pharma, clinical, and startup execs addressing some of the biggest challenges facing their businesses today?

Dr. Ashish Atreja, Icahn School of Medicine

Dr. Ashish Atreja, Icahn School of Medicine

Dr. Ashish Atreja is the director of the Sinai AppLab at the Icahn School of Medicine.

Dr. Susan Kornstein, Virginia Commonwealth University

Dr. Susan Kornstein, Virginia Commonwealth University

Dr. Susan Kornstein is co-founder and executive director of the Virginia Commonwealth University Institute for Women's Health.

Nothing Will Replace Human Doctors, Not Even Robots

Nothing Will Replace Human Doctors, Not Even Robots

Healthcare is one industry that hangs in this delicate balance, in large part due to the fact that it necessitates a blend of science and empathy.

Five things for pharma marketers to know: Friday, March 31, 2017

Five things for pharma marketers to know: Friday, March 31, 2017

By

Novartis ordered to turn over files about 80,000 speaking events; drugmakers set lower-than-expected prices at launch; funding goes to R&D of antibiotics

What doctors have to say about those DTC ads

What doctors have to say about those DTC ads

By

We had SERMO, a social network for physicians, ask about 1,700 physicians what they have to say about the impact of DTC on patient care and choices. Note: It's not pretty.

Healthgrades' Eric Jensen on providing quality of life

Healthgrades' Eric Jensen on providing quality of life

By

Healthcare is sometimes about life or death, but is almost always about quality of life, says the EVP of health system products and strategy.

Digital IDs become focus as drugmakers seek to track doctors' behavior online

Digital IDs become focus as drugmakers seek to track doctors' behavior online

By

Organizations are focusing on better ways to verify HCPs' digital identities.

Klara's Simon Lorenz on breaking away from the physician lifestyle

Klara's Simon Lorenz on breaking away from the physician lifestyle

By

He instead decided to find a way to make a physician's job easier by creating a clinical messaging platform.

Some CME experts remain skeptical when it comes to social media

Some CME experts remain skeptical when it comes to social media

By

There are also issues surrounding privacy and legitimacy. According to one expert's research, very few physicians use social media for professional purposes.

Doctors seek more transparency from drugmakers: ePharma panel

Doctors seek more transparency from drugmakers: ePharma panel

By

Pharmaceutical companies often blur the lines between a drug's risks and benefits in ads, and that frustrates physicians.

Infographic: What's next for the point of care market

Infographic: What's next for the point of care market

About 30% of patients are more likely to fill a prescription after being exposed to healthcare ads at the point of care, according to Kantar Media.

Five things for pharma marketers to know: Friday, February 17, 2017

Five things for pharma marketers to know: Friday, February 17, 2017

By

Microsoft reenters healthcare market; Trump accuses Cummings of avoiding drug-pricing meeting; Trump says ACA replacement plan to be unveiled in March

How To Make A Doctor Happy: Take Away the Brand Message in a Drug Ad

How To Make A Doctor Happy: Take Away the Brand Message in a Drug Ad

The presumption is Dr. A saw ad B, clicked on it, went to the site and within C time, prescribed product D.

Infographic: Can pharma give doctors what they want?

Infographic: Can pharma give doctors what they want?

Physicians do not like EHRs. That much is clear. But the vast majority have to use electronic record systems on a daily basis. What can pharma do to better give doctors what they want?

CME providers use Facebook Live to educate doctors

CME providers use Facebook Live to educate doctors

By

A recent CME course using Facebook Live generated 34,000 views and 600 comments.

Five things for pharma marketers to know: Friday, December 16, 2016

Five things for pharma marketers to know: Friday, December 16, 2016

By

Allergan to settle allegations relating to speakers bureaus; Mylan launches generic version of the EpiPen; 20 states sue six drugmakers accused of price-fixing

An EHR strategy can't be measured in clicks, says Lilly exec

An EHR strategy can't be measured in clicks, says Lilly exec

By

Pharma can reach physicians within the EHR, but they must send the right message at the right time, she said at an MM&M event.

MM&M's top 5 stories in November 2016

MM&M's top 5 stories in November 2016

By

How VR, nanotechnology, and 3D printing could improve the value of healthcare; 100 experimental therapies in late-stage clinical trials; Kite Pharma plans "controlled" launch of CAR-T therapy

The doctor-patient dialogue: As productive as it's ever been or broken?

The doctor-patient dialogue: As productive as it's ever been or broken?

By

More barriers separate doctors and patients than ever before, from rising costs and time constraints to electronic health records and smartphones.